217 related articles for article (PubMed ID: 23287431)
1. Diagnostic strategies to investigate cerebrospinal fluid involvement in haematological malignancies.
Galati D; Di Noto R; Del Vecchio L
Leuk Res; 2013 Mar; 37(3):231-7. PubMed ID: 23287431
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid approach on neuro-oncology.
Gomes HR
Arq Neuropsiquiatr; 2013 Sep; 71(9B):677-80. PubMed ID: 24141503
[TBL] [Abstract][Full Text] [Related]
3. Utility and proposed algorithm of CSF flow cytometry in hematologic malignancies.
Tawfik B; Brown L; Fuda F; Chen W; Niu S; Sailors J; Sadeghi N
Ann Hematol; 2018 Sep; 97(9):1707-1716. PubMed ID: 29680874
[TBL] [Abstract][Full Text] [Related]
4. Significance of cerebrospinal fluid sIL-2R level as a marker of CNS involvement in acute lymphoblastic leukemia.
Lee W; Kim SJ; Lee S; Kim J; Kim M; Lim J; Kim Y; Cho B; Lee EJ; Han K
Ann Clin Lab Sci; 2005; 35(4):407-12. PubMed ID: 16254256
[TBL] [Abstract][Full Text] [Related]
5. Autotaxin and soluble IL-2 receptor concentrations in cerebrospinal fluids are useful for the diagnosis of central nervous system invasion caused by haematological malignancies.
Shimura T; Kurano M; Morita Y; Yoshikawa N; Nishikawa M; Igarashi K; Shimamoto S; Aoki J; Yatomi Y
Ann Clin Biochem; 2019 Mar; 56(2):240-246. PubMed ID: 30514094
[TBL] [Abstract][Full Text] [Related]
6. CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies.
Bromberg JE; Breems DA; Kraan J; Bikker G; van der Holt B; Smitt PS; van den Bent MJ; van't Veer M; Gratama JW
Neurology; 2007 May; 68(20):1674-9. PubMed ID: 17502548
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid lactate dehydrogenase isoenzyme analysis for the diagnosis of central nervous system involvement in hematooncologic patients.
Lossos IS; Breuer R; Intrator O; Lossos A
Cancer; 2000 Apr; 88(7):1599-604. PubMed ID: 10738218
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid involvement in mantle cell lymphoma.
Valdez R; Kroft SH; Ross CW; Schnitzer B; Singleton TP; Peterson LC; Finn WG
Mod Pathol; 2002 Oct; 15(10):1073-9. PubMed ID: 12379754
[TBL] [Abstract][Full Text] [Related]
9. D-dimer levels in the cerebrospinal fluid: a marker of central nervous system involvement in neoplastic disease.
Eclache V; Vu T; Le Roux G
Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):321-4. PubMed ID: 7971253
[TBL] [Abstract][Full Text] [Related]
10. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F
Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
[TBL] [Abstract][Full Text] [Related]
11. Case series: CSF LDH, proteins and electrolyte levels in patients of acute lymphocytic leukemia.
Rao D; Ghalaut VS; Ghalaut PS; Rao S
Clin Chim Acta; 2012 Jul; 413(13-14):1045-8. PubMed ID: 22387722
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment.
Chamberlain MC; Glantz M; Groves MD; Wilson WH
Semin Oncol; 2009 Aug; 36(4 Suppl 2):S35-45. PubMed ID: 19660682
[TBL] [Abstract][Full Text] [Related]
13. Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system.
Baraniskin A; Deckert M; Schulte-Altedorneburg G; Schlegel U; Schroers R
Br J Haematol; 2012 Feb; 156(4):421-32. PubMed ID: 22077417
[TBL] [Abstract][Full Text] [Related]
14. Meningeal spread of blastic plasmacytoid dendritic cell neoplasm.
Starck M; Zewen S; Eigler A; Wendtner CM
Eur J Haematol; 2014 Aug; 93(2):175-6. PubMed ID: 24483771
[No Abstract] [Full Text] [Related]
15. Is CSF cytology a useful diagnostic procedure in staging paediatric CNS tumours?
Cohen NR; Phipps K; Harding B; Jacques TS
Cytopathology; 2009 Aug; 20(4):256-60. PubMed ID: 19659957
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis, prophylaxis and treatment of central nervous system involvement by non-Hodgkin lymphoma in HIV-infected patients].
Miralles P; Berenguer J; Ribera JM;
Med Clin (Barc); 2010 Sep; 135(9):417-22. PubMed ID: 19628233
[TBL] [Abstract][Full Text] [Related]
17. ESCCA/ISCCA protocol for the analysis of cerebrospinal fluid by multiparametric flow-cytometry in hematological malignancies.
Del Principe MI; Gatti A; Johansson U; Buccisano F; Brando B
Cytometry B Clin Cytom; 2021 May; 100(3):269-281. PubMed ID: 33369082
[TBL] [Abstract][Full Text] [Related]
18. How to facilitate early diagnosis of CNS involvement in malignant lymphoma.
Korfel A; Nowosielski M; Pardo-Moreno J; Penalver FJ; Buda G; Bennani H; Costopoulos M; Le Garff-Tavernier M; Soussain C; Schmid M; Orfao JA; Glantz M
Expert Rev Hematol; 2016 Nov; 9(11):1081-1091. PubMed ID: 27677656
[TBL] [Abstract][Full Text] [Related]
19. CXCL13 and CXCL12 in central nervous system lymphoma patients.
Fischer L; Korfel A; Pfeiffer S; Kiewe P; Volk HD; Cakiroglu H; Widmann T; Thiel E
Clin Cancer Res; 2009 Oct; 15(19):5968-73. PubMed ID: 19773382
[TBL] [Abstract][Full Text] [Related]
20. Advances in the analysis of cerebrospinal fluid.
Knight JA
Ann Clin Lab Sci; 1997; 27(2):93-104. PubMed ID: 9098508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
